ROCHESTER, N.Y. (PRWEB)
January 09, 2020

CHESS Health, the leading provider of addiction management technology, and PACE, a Delaware-based operator of drug and alcohol rehabilitation programs, are working together to offer all aspects of the CHESS platform to the PACE patient population.

PACE has been using the CHESS eRecovery solution since August of this year and quickly measured a 20% increase in treatment adherence among patients active with the Connections app. When surveyed, PACE’s patients gave the CHESS platform a 90% or better approval rating across multiple measures and 97% of all patients recommended PACE keep the Connections app as part of its treatment program.

In addition to eRecovery, PACE recently began offering eTherapy in its intensive outpatient (IOP) program; eTherapy is the CHESS evidence-based digital tool for teaching key recovery skills using cognitive behavioral therapy (CBT). PACE will also implement the CHESS eIntervention solution to coordinate care with other providers in the community, including MAT providers, as well as to engage prospective patients and their families.

“When I started my counseling work in 1986, if you told me that technology delivered over a phone could really help with addiction, I’d think you were crazy,” says Bruce Johnson, executive director of PACE. “The Connections app is so valuable for removing barriers to asking for help, and gets people plugged into a community faster. The entire CHESS platform is transforming how we treat patients and coordinate with the community.”

“Addiction management technology will help strengthen and extend the scope of the great work that PACE is already doing for its patients,” says Hans Morefield, chief executive officer of CHESS. “We are especially proud of the feedback from their patients – our mission every day is to improve the lives of individuals struggling with the disease of addiction.”

About CHESS Health

CHESS Health is the developer of the leading, evidence-based technology platform for the addiction management life cycle. The platform facilitates digital handoffs for getting more patients into treatment (eIntervention); improves outcomes through digital CBT (eTherapy) and reduces relapse and supports long term recovery (eRecovery). For providers, the CHESS platform grows patient volume through more successful referrals, improves treatment delivery, and measure better outcomes, including reduced relapse. Health plans and governments also benefit from more individuals in treatment and better outcomes; with the CHESS platform, they also gain analytic insights into provider performance. CHESS Health has received recognition from the Substance Abuse and Mental Health Services Administration’s National Registry of Evidence-based Programs and Practices (NREPP), the Journal of Substance Abuse and the Surgeon General. For more information, visit http://www.chess.health.

About Pace

For more information, visit paceinconline.com.

Share article on social media or email:

CHICAGO (PRWEB)
January 09, 2020

Impact Advisors, a leading provider of clinical, revenue cycle and information technology services to the healthcare industry, announced that John Klare has joined its team to lead the Performance Excellence service line for the firm.

“We are elated to have John on our leadership team,” said Andy Smith, president and co-founder of Impact Advisors. “His experience and track record in the industry will position us to make an even bigger impact for our clients as they react to a rapidly changing environment. In addition, John’s passion for growing and developing top talent is a perfect match for our culture.”

Klare has more than 30 years of experience in the healthcare industry with proven success at previous organizations where he has grown both service offerings and associates, creating high-performing practices. During his career, he has successfully helped organizations with provider business transformation, operations improvement and revenue cycle. In addition, he has an outstanding track record in new business development, new service line development and new client acquisition for complex consulting and business processing outsourcing contracts.

Impact Advisors’ Performance Excellence service line is an extension of its management consulting services and is designed to help clients improve their operating and financial performance through a balanced approach, including quality and service enhancements, revenue growth, and cost reduction, as well as provider and patient engagement. With this offering, Impact provides tech-enabled solutions to help clients create sustainable improvements with existing IT investments. In addition, Performance Excellence will allow the firm to leverage and integrate its full suite of services to provide a full continuum of value to its clients, helping them exceed their expectations.

Klare has a Master of Business Administration in Finance and Health Administration from the University of Chicago.

About Impact Advisors

Impact Advisors is a nationally recognized healthcare consulting firm that is solving some of the toughest challenges in the industry by delivering strategic advisory, technology implementation and performance improvement services. Our comprehensive suite of digital health, clinical optimization and revenue cycle services spans the lifecycle of our clients’ needs. Our experienced team has a powerful combination of clinical, revenue, operations, consulting and IT experience. The firm has earned a number of prestigious industry and workplace awards, including Best in KLAS® for 12 consecutive years, Healthcare Informatics HCI 100, Crain’s Chicago Business Fast Fifty, as well as “best place to work” awards from: Modern Healthcare, Consulting Magazine, Becker’s Hospital Review and Achievers. For more information about Impact Advisors, visit http://www.impact-advisors.com.

Share article on social media or email:

PORTLAND, Ore. (PRWEB)
January 09, 2020

Owl Insights, the leading provider of precision care management technology for behavioral health announced the appointment of Patrick Kennedy, founder of the Kennedy Forum and One Mind, as a strategic advisor effective immediately.

“Patrick brings a personal perspective and deep understanding of the single biggest health care crisis in America, effective treatment for substance use and mental health disorders,” said Eric Meier, chief executive officer of Owl Insights. “His desire to join us in our mission of supporting behavioral health providers to address patient access and improve clinical outcomes nationwide is met with tremendous gratitude.”

Kennedy joins Owl Insights with 35 years of experience as a legislator, serving 16 years in Congress and then consulting on increasing the understanding and treatment of neurological and psychiatric disorders within the healthcare industry. While in Congress, he was the principal author of the federal law known as the Mental Health Parity and Addiction Equity Act. In 2013 he founded The Kennedy Forum, a non-profit organization whose mission is to lead a national dialogue on transforming mental health and addiction care delivery by uniting mental health advocates, business leaders, and government agencies around a common set of principles, including full implementation of the Federal Parity Law. And in the spring of 2017, Kennedy was appointed to serve on the President’s Commission on Combating Drug Addiction and the Opioid Crisis.

“Owl Insights addresses a significant issue facing behavioral health providers, the ability to offer a personalized and effective approach to treatment,” said Kennedy. “As a strategic advisor, I am excited to be part of the Owl Insights team and its data-driven approach to improving both access and the treatment experience for patients and their families seeking effective behavioral health care.”

In 2015, Kennedy co-authored the New York Times Bestseller, “A Common Struggle: A Personal Journey Through the Past and Future of Mental Illness and Addiction.” His expertise and transparency around behavioral health concerns make him a unique contributor to the Owl Insights mission.

For more information on Owl Insights Precision Care Management Platform for Behavioral Health, visit http://www.owlinsights.com.

About Owl Insights

Owl Insights, Inc., is the leading provider of precision care management technology for behavioral health (BH). Through its advanced platform, affectionately termed “The Owl,” the company offers a scalable strategy to integrate measurement-based care and clinical analytics into existing BH treatment workflows covering all major behavioral health conditions. Owl Insights supports health systems and independent BH organizations nationwide to expand access, improve quality care delivery, better manage costs and support the preparation for value-based care. For more information, visit http://www.owlinsights.com.

Share article on social media or email:

CHARLOTTE, N.C. (PRWEB)
January 09, 2020

FastMed Urgent Care, one of the nation’s largest urgent care providers, has relocated within Mooresville and is now open at its expanded location at 168 Norman Station Blvd., Suite Q. This clinic is one of 58 FastMed locations in North Carolina.

The Mooresville FastMed Urgent Care clinic is open seven days a week and holidays. It offers no-appointment necessary services for flu prevention and treatment, labs and x-rays, school or sports physicals, vaccinations and immunizations, women’s health and more.

“Over the last eight years I’ve been with FastMed, we’ve had the opportunity to help meet the healthcare needs of the Mooresville community,” said Steve Floyd, P.A., area medical manager for the Mooresville clinic. “We are thrilled to continue to serve our patients in this new and expanded clinic. This clinic has proudly earned a reputation for providing easy access to high-quality healthcare and we are fortunate to expand our physical footprint to better meet the needs of the community.”

With a total of 109 clinics located across North Carolina, Texas and Arizona, FastMed has become one of the largest urgent care providers in the country.

The Mooresville clinic will be open Monday – Friday from 8 a.m. – 8 p.m. Saturday and Sunday from 8 a.m. – 4 p.m. For more information or to book your appointment online, visit https://www.fastmed.com/urgent-care-centers/mooresville-nc-walk-in-clinic/ or call (704) 235-0686.

About FastMed Urgent Care

FastMed Urgent Care owns and operates 109 clinics in North Carolina, Arizona and Texas, providing a broad range of acute/episodic and preventive healthcare services 365 days per year. FastMed also provides workers’ comp services at all of its clinics, and family and sports medicine services at select locations. FastMed has successfully treated more than 5.8 million patients since the opening of its first clinic in 2005, and is the largest urgent care operator to be awarded the Joint Commission Gold Seal of Approval® for accreditation in healthcare quality and safety in ambulatory healthcare. For more information about locations, services, hours of operation, insurance and prices, visit http://www.FastMed.com.

Share article on social media or email:

SCOTTSDALE, Ariz. (PRWEB)
January 09, 2020

Attainia, the market leader in cloud-based software for medical equipment (FF&E) planning, routine annual capital replacement, tracking and analytics, today announced the launch of a new partnership with Accruent, the leading provider of healthcare technology (HTM) and facilities management (HFM) solutions that optimize asset and maintenance management.

To manage — and reduce — total cost of capital equipment assets, healthcare systems and hospitals must have access to critical data that informs and guides purchasing decisions. The partnership will help healthcare delivery organizations manage their full equipment asset lifecycles and facilitate incremental cost reductions, allowing for improved quality of patient care. Only by consolidating and analyzing data system-wide, and enforcing standardization practices, can healthcare providers negotiate the most favorable purchasing terms and drive out costs from new construction, renovation and routine capital replacement projects. The Attainia / Accruent partnership will support cross-access to tools which are developed specifically to enhance existing processes and to identify all cost-savings opportunities available.

Using the combination of Attainia and Accruent software tools provide critical capabilities and benefits for healthcare organizations, including:

• The industry’s only integrated furniture, fixtures and equipment (FF&E) product supplier catalog that drives organizational standards with more than 3,200 suppliers that feature more than 63,000 products.
• An online collaboration environment for equipment planning using workflows to ensure that processes are efficient and accurate, which can dramatically reduce the number of change orders.
• Visibility into all planned capital equipment for new construction, renovation, expansion and annual replacement requests that maximize the ability to negotiate volume discounts with suppliers and group purchasing organizations (GPOs).

“The Accruent and Attainia partnership will dramatically impact the way our healthcare clients and future prospects manage their capital equipment,” said DJ Chhabra, Attainia CEO and chairman of the board. “Each company has a leading market position with healthcare planning solutions, and the synergy of our products will allow us to provide integrated data insights and an improved client experience in the planning and management of capital equipment. I’m very excited about how this partnership will enhance both organizations’ solutions and deliver improved outcomes for our healthcare clients.”

Currently, Accruent serves more than 55 percent of U.S. hospitals, providing capital planning, healthcare technology management, and facilities management software and services. Attainia provides capital equipment planning and replacement software and analytics to more than 1,000 hospitals.

“A comprehensive capital lifecycle management program can save millions of dollars for a healthcare organization,” noted Al Gresch, Accruent vice president of healthcare customer success, who helped build such systems for three different organizations. “To build such a system requires significant expertise, time, and resources. With this partnership, most of the heavy lifting is done for you and it makes that model achievable for any organization.”

About Attainia

attainia.com, @attainia

Used by more than 1,000 member hospitals, Attainia is the most widely implemented medical equipment planning, budgeting, and analytics software solution for healthcare equipment (FF&E) planning and routine replacement. Attainia drives informed healthcare equipment asset decisions by providing real-time insights, project management support, and powerful collaboration solutions in a thoughtfully-designed cloud-based software platform.

Contact Attainia

Dianna Sovine, 480-648-1697

dianna.sovine@attainia.com

About Accruent

accruent.com, @accruentllc

Accruent is the world’s leading provider of intelligent solutions for the built environment – a $10Bn market spanning real estate, physical and digital assets, and the integrated technology systems that connect and control them. Accruent continues to set new expectations for how organizations can use data to transform the way they manage their facilities and assets. With major office locations in Austin, New Orleans, London and Amsterdam, Accruent serves more than 10,000 customers in a wide range of industries in more than 150 countries around the world.

Contact Accruent

Wayne Henninger, 1-570-573-6556

wayne@waynehenninger.com

Share article on social media or email:

SAN DIEGO (PRWEB)
January 09, 2020

Cardea Bio, a new (bio)technology infrastructure company pioneering the development of biology-gated transistors to integrate biology and electronics, announced today that it has added four highly successful and experienced leaders to its senior management team.

• 
  Dr. Paul Grint as Chairman of Innovation Council
• Jonathan Seaton as Senior Vice President, Corporate & Business Development
• Rob Lozuk as Senior Vice President, Commercial Operations

With decades of combined experience ranging from Paul Grint’s time as the former CEO of AmpliPhi and an Illumina Board member, Jonathan Seaton, Illumina’s former Senior Vice President (SVP) of Corporate & Business Development, after VP positions at BD Life Sciences and Roche, and Rob Lozuk’s executive positions at Sequenom and Thermo Fisher Scientific, Cardea has just positioned itself for accelerated growth under an experienced leadership team.

“This talent infusion enables Cardea to accelerate our business while validating the attractiveness of our vision and the substantial opportunity in front of us. We are thrilled to bring these exceptional people onboard to realize our vision of helping the world Conduct Biology™,” says CEO, Michael Heltzen.

Cardea has appointed Paul Grint, MD as its Chairman of the inaugural Cardea Innovation Council. In this position, Dr. Grint will lead a group of high-profile Innovation advisors and experts, who will be announced later in Q1 2020. Dr. Grint is a proven biotechnology executive with more than two decades of experience leading both established and emerging biotech companies working in the areas of infectious disease, immunology, and oncology.

Most recently, Dr. Grint was CEO and a member of the board of directors of AmpliPhi Biosciences, which recently merged with C3J Therapeutics to form Armata Pharmaceuticals. Dr. Grint has also served in senior management roles at Cerexa, Forest Laboratories, Kalypsys, Pfizer, IDEC Pharmaceuticals, and Schering-Plough Corporation.

“Cardea has created an entirely new way for scientists from any industry to access biology. The Innovation Council will leverage our members’ diverse technology and industry backgrounds from life sciences, bioinformatics, agriculture, electronics, diagnostics as well as food and environmental safety to identify innovation partners and new solutions to industry bottlenecks and problems,” said Dr. Grint.

Cardea’s Innovation Council is actively engaged in supporting the company’s mission to connect the domain of biology to more traditional technology and computer infrastructures, enabling greater access to bio-data in numerous applications; now referred to as the “Internet of Biology”.

Jonathan Seaton has joined Cardea as SVP for Corporate & Business Development where Mr. Seaton’s access to peers in the global life science world will be the starting point for more product co-development partnerships. Cardea’s biology-based transistor infrastructure will offer partner’s the tech modules to create a new generation of life science applications and devices branded and sold under the partner’s brand.

Prior to joining Cardea, Mr. Seaton held the position of SVP, Corporate & Business Development at Illumina, and prior to that he was VP, Strategy and Business Development at BD Life Sciences and Vice Director, Global Business Development at Roche Diagnostics.

“Cardea is pioneering a new method of life science detection and expanding the scope of possible insights. The Cardean infrastructure is not just generating data-sets, but also the data-streams of interactive signals from systems biology. It even allows for multi-omics analysis due to the biocompatible graphene transistors, which do not require the amplification and optics that often are the bottlenecks in life sciences,” says Mr. Seaton.

Rob Lozuk has been assisting Cardea throughout most of 2019 as an executive business consultant. Rob was initially responsible for building the Cardea Innovation Partnership Program and is now transitioning into a broader role as Cardea’s SVP of Commercial Operations, a role he also held previously at Sequenom, where he was responsible for sales, marketing, commercial and laboratory operations.

“Through our Innovation Partnership Program, Cardea is working with a select group of prestigious partners to create a new generation of “Internet of Biology” enabled products. Cardea’s proprietary, biology-gated transistor infrastructure will have an enormous impact on the world as partners will now be able to market new “biology is technology” applications inside instruments and/or portable devices only once imagined,” says Mr. Lozuk.

“It’s rare to have a detection breakthrough that significantly expands the number and type of applications within and outside of the traditional life science markets. Cardea’s technology leverages all of the learnings and methods of scaling from the well-established semiconductor industry while opening a whole new playing field in-between biology and electronics that has the capability of bringing valuable insights to every human being on the planet,” continues Mr. Lozuk.

About Cardea Bio

Cardea Bio is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors (“Cardean transistors”). Cardean transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with direct electrical molecular signal analysis. Until now, life science data was comprised of static snapshot datasets. With Cardean transistors, the company and its Innovation Partners can generate streaming multi-omics data to measure real-time biological signals. Cardea is now manufacturing chips at scale and partners have started to significantly expand the amount, type and quality of biological data they capture by building products that Conduct Biology™. Cardea is headquartered in San Diego, California.

For more information, please visit cardeabio.com and engage with us on Twitter @Cardeabio or on LinkedIn.

Share article on social media or email: